Edward Nash's Stock Ratings

Canaccord Genuity Analyst

Edward Nash is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025

Overall Average Return

16.5%

Smart Score

67%

Overall Average Return Percentile

75th

Number of Ratings

104
Buy NowGet Alert
02/26/2025RANIBuy Now
Rani Therapeutics Hldgs
$1.44525%
Edward Nash66%
$9 → $9MaintainsBuyGet Alert
02/12/2025VRNABuy Now
Verona Pharma
$66.658.03%
Edward Nash66%
$44 → $72MaintainsBuyGet Alert
02/12/2025TVTXBuy Now
Travere Therapeutics
$21.05113.78%
Edward Nash66%
$22 → $45MaintainsBuyGet Alert
02/10/2025PLRXBuy Now
Pliant Therapeutics
$1.52163.18%
Edward Nash66%
→ $4DowngradeBuy → HoldGet Alert
01/30/2025CORTBuy Now
Corcept Therapeutics
$58.32122.91%
Edward Nash66%
$78 → $130MaintainsBuyGet Alert
01/28/2025AKROBuy Now
Akero Therapeutics
$45.2461.36%
Edward Nash66%
$56 → $73MaintainsBuyGet Alert
11/25/2024APGEBuy Now
Apogee Therapeutics
$39.00128.21%
Edward Nash66%
→ $89Initiates → BuyGet Alert
11/05/2024VRNABuy Now
Verona Pharma
$66.65-33.98%
Edward Nash66%
$37 → $44MaintainsBuyGet Alert
09/30/2024TVTXBuy Now
Travere Therapeutics
$21.054.51%
Edward Nash66%
$23 → $22MaintainsBuyGet Alert
09/10/2024TVTXBuy Now
Travere Therapeutics
$21.059.26%
Edward Nash66%
$18 → $23MaintainsBuyGet Alert
08/12/2024VTYXBuy Now
Ventyx Biosciences
$1.31968.7%
Edward Nash66%
$15 → $14MaintainsBuyGet Alert
07/31/2024CORTBuy Now
Corcept Therapeutics
$58.3233.74%
Edward Nash66%
$38 → $78MaintainsBuyGet Alert
07/30/2024CORTBuy Now
Corcept Therapeutics
$58.32-34.84%
Edward Nash66%
$38 → $38MaintainsBuyGet Alert
07/22/2024VRNABuy Now
Verona Pharma
$66.65-44.49%
Edward Nash66%
$35 → $37MaintainsBuyGet Alert
06/27/2024VRNABuy Now
Verona Pharma
$66.65-47.49%
Edward Nash66%
$35 → $35MaintainsBuyGet Alert
05/23/2024CRDLBuy Now
Cardiol Therapeutics
$1.06654.72%
Edward Nash66%
$6 → $8MaintainsBuyGet Alert
05/13/2024AKROBuy Now
Akero Therapeutics
$45.2423.78%
Edward Nash66%
$59 → $56MaintainsBuyGet Alert
05/07/2024TVTXBuy Now
Travere Therapeutics
$21.05-14.49%
Edward Nash66%
$15 → $18MaintainsBuyGet Alert
04/08/2024IVABuy Now
Inventiva
$2.97573.4%
Edward Nash66%
$12 → $20MaintainsBuyGet Alert
03/27/2024RANIBuy Now
Rani Therapeutics Hldgs
$1.44525%
Edward Nash66%
$21 → $9MaintainsBuyGet Alert
03/15/2024MDGLBuy Now
Madrigal Pharmaceuticals
$343.299.82%
Edward Nash66%
$338 → $377MaintainsBuyGet Alert
03/13/2024VTYXBuy Now
Ventyx Biosciences
$1.311045.04%
Edward Nash66%
$16 → $15MaintainsBuyGet Alert
03/11/2024VTYXBuy Now
Ventyx Biosciences
$1.311121.37%
Edward Nash66%
$20 → $16MaintainsBuyGet Alert
03/08/2024MORFBuy Now
Morphic Holding
——
Edward Nash66%
$68 → $66MaintainsBuyGet Alert
03/08/2024MDGLBuy Now
Madrigal Pharmaceuticals
$343.29-1.54%
Edward Nash66%
$336 → $338MaintainsBuyGet Alert
12/13/2023CORTBuy Now
Corcept Therapeutics
$58.32-34.84%
Edward Nash66%
$37 → $38MaintainsBuyGet Alert
10/27/2023IVABuy Now
Inventiva
$2.97304.04%
Edward Nash66%
→ $12Initiates → BuyGet Alert
09/27/2023ICPTBuy Now
Intercept Pharma
——
Edward Nash66%
$20 → $19DowngradeBuy → HoldGet Alert
09/01/2023VRNABuy Now
Verona Pharma
$66.65-47.49%
Edward Nash66%
→ $35ReiteratesBuy → BuyGet Alert
08/25/2023CORTBuy Now
Corcept Therapeutics
$58.32-39.99%
Edward Nash66%
$34 → $35MaintainsBuyGet Alert
08/03/2023ICPTBuy Now
Intercept Pharma
——
Edward Nash66%
$19 → $20MaintainsBuyGet Alert
07/18/2023TVTXBuy Now
Travere Therapeutics
$21.0566.27%
Edward Nash66%
$37 → $35MaintainsBuyGet Alert
07/18/2023MDGLBuy Now
Madrigal Pharmaceuticals
$343.29-2.12%
Edward Nash66%
→ $336ReiteratesBuy → BuyGet Alert
07/03/2023THTXBuy Now
Theratechnologies
$2.19-8.68%
Edward Nash66%
→ $8Assumes → HoldGet Alert
06/29/2023ICPTBuy Now
Intercept Pharma
——
Edward Nash66%
—UpgradeHold → BuyGet Alert
06/21/2023DICEBuy Now
DICE Therapeutics
——
Edward Nash66%
$71 → $48DowngradeBuy → HoldGet Alert
06/20/2023DICEBuy Now
DICE Therapeutics
——
Edward Nash66%
$71 → $48DowngradeBuy → HoldGet Alert
05/23/2023ICPTBuy Now
Intercept Pharma
——
Edward Nash66%
$26 → $12MaintainsHoldGet Alert
05/22/2023DICEBuy Now
DICE Therapeutics
——
Edward Nash66%
→ $71Initiates → BuyGet Alert
05/19/2023RZLTBuy Now
Rezolute
$2.89488.24%
Edward Nash66%
$16 → $17MaintainsBuyGet Alert
05/19/2023CRDLBuy Now
Cardiol Therapeutics
$1.06466.04%
Edward Nash66%
$5 → $6MaintainsBuyGet Alert
05/18/2023PLRXBuy Now
Pliant Therapeutics
$1.523058.1%
Edward Nash66%
→ $48Initiates → BuyGet Alert
05/17/2023AKROBuy Now
Akero Therapeutics
$45.2430.42%
Edward Nash66%
$58 → $59MaintainsBuyGet Alert
05/17/2023ORMPBuy Now
Oramed Pharmaceuticals
$2.33-14.16%
Edward Nash66%
$3 → $2MaintainsHoldGet Alert
05/10/2023VRNABuy Now
Verona Pharma
$66.65-50.49%
Edward Nash66%
$31 → $33MaintainsBelow AverageGet Alert
05/10/2023MDGLBuy Now
Madrigal Pharmaceuticals
$343.29-2.12%
Edward Nash66%
→ $336Reiterates → BuyGet Alert
03/21/2023AKROBuy Now
Akero Therapeutics
$45.2428.21%
Edward Nash66%
$50 → $58MaintainsBuyGet Alert
03/08/2023CORTBuy Now
Corcept Therapeutics
$58.32-45.13%
Edward Nash66%
$33 → $32MaintainsBuyGet Alert
02/28/2023MDGLBuy Now
Madrigal Pharmaceuticals
$343.29-2.12%
Edward Nash66%
$296 → $336MaintainsBuyGet Alert
02/28/2023TVTXBuy Now
Travere Therapeutics
$21.0599.52%
Edward Nash66%
$44 → $42MaintainsBuyGet Alert
02/22/2023TVTXBuy Now
Travere Therapeutics
$21.05109.03%
Edward Nash66%
$40 → $44MaintainsBuyGet Alert
01/31/2023VTYXBuy Now
Ventyx Biosciences
$1.314022.14%
Edward Nash66%
$35 → $54MaintainsBuyGet Alert
01/30/2023TVTXBuy Now
Travere Therapeutics
$21.0590.02%
Edward Nash66%
$33 → $40MaintainsBuyGet Alert
01/12/2023ORMPBuy Now
Oramed Pharmaceuticals
$2.33—
Edward Nash66%
—DowngradeBuy → HoldGet Alert
01/10/2023AMYTBuy Now
Amryt Pharma
——
Edward Nash66%
$19 → $17DowngradeBuy → HoldGet Alert
09/06/2022AMYTBuy Now
Amryt Pharma
——
Edward Nash66%
→ $19Assumes → BuyGet Alert
08/17/2022VTYXBuy Now
Ventyx Biosciences
$1.312571.76%
Edward Nash66%
$30 → $35MaintainsBuyGet Alert
08/08/2022GLMDBuy Now
Galmed Pharmaceuticals
$1.81-44.75%
Edward Nash66%
$900 → $180DowngradeBuy → HoldGet Alert
08/05/2022CCXIBuy Now
ChemoCentryx
——
Edward Nash66%
→ $52DowngradeBuy → HoldGet Alert
08/04/2022CCXIBuy Now
ChemoCentryx
——
Edward Nash66%
→ $81Assumes → BuyGet Alert
08/02/2022RZLTBuy Now
Rezolute
$2.89488.24%
Edward Nash66%
→ $17Assumes → BuyGet Alert
07/14/2022TVTXBuy Now
Travere Therapeutics
$21.0599.52%
Edward Nash66%
→ $42Assumes → BuyGet Alert
05/10/2022ICPTBuy Now
Intercept Pharma
——
Edward Nash66%
$29 → $26MaintainsHoldGet Alert
04/26/2022OBSVBuy Now
ObsEva
——
Edward Nash66%
→ $12Initiates → BuyGet Alert
03/31/2022MORFBuy Now
Morphic Holding
——
Edward Nash66%
→ $68Initiates → BuyGet Alert
03/31/2022VTYXBuy Now
Ventyx Biosciences
$1.312190.08%
Edward Nash66%
→ $30Initiates → BuyGet Alert
03/08/2022ICPTBuy Now
Intercept Pharma
——
Edward Nash66%
$31 → $29MaintainsHoldGet Alert
12/03/2021CRDLBuy Now
Cardiol Therapeutics
$1.06654.72%
Edward Nash66%
→ $8Initiates → BuyGet Alert
11/12/2021VRNABuy Now
Verona Pharma
$66.65-65.49%
Edward Nash66%
$18 → $23MaintainsBuyGet Alert
10/22/2021MTCRBuy Now
Metacrine
——
Edward Nash66%
$19 → $1DowngradeBuy → HoldGet Alert
08/03/2021ICPTBuy Now
Intercept Pharma
——
Edward Nash66%
$43 → $31MaintainsHoldGet Alert
07/29/2021ORMPBuy Now
Oramed Pharmaceuticals
$2.331187.55%
Edward Nash66%
$27 → $30MaintainsBuyGet Alert
07/29/2021THTXBuy Now
Theratechnologies
$2.1936.99%
Edward Nash66%
$32 → $12DowngradeBuy → HoldGet Alert
05/17/2021GLMDBuy Now
Galmed Pharmaceuticals
$1.811060.22%
Edward Nash66%
$3600 → $3780MaintainsBuyGet Alert
05/17/2021MDGLBuy Now
Madrigal Pharmaceuticals
$343.29-43.78%
Edward Nash66%
$179 → $193MaintainsBuyGet Alert
05/03/2021VRNABuy Now
Verona Pharma
$66.65-72.99%
Edward Nash66%
$19 → $18MaintainsBuyGet Alert
04/20/2021ORMPBuy Now
Oramed Pharmaceuticals
$2.331058.8%
Edward Nash66%
→ $27Initiates → BuyGet Alert
04/19/2021THTXBuy Now
Theratechnologies
$2.19265.3%
Edward Nash66%
$28 → $32MaintainsBuyGet Alert
03/18/2021AKROBuy Now
Akero Therapeutics
$45.241.68%
Edward Nash66%
$51 → $46MaintainsBuyGet Alert
11/12/2020MDGLBuy Now
Madrigal Pharmaceuticals
$343.29-48.44%
Edward Nash66%
$198 → $177MaintainsBuyGet Alert
11/11/2020ICPTBuy Now
Intercept Pharma
——
Edward Nash66%
$42 → $58MaintainsHoldGet Alert
10/12/2020MTCRBuy Now
Metacrine
——
Edward Nash66%
→ $19Initiates → BuyGet Alert
08/10/2020VRNABuy Now
Verona Pharma
$66.65-74.49%
Edward Nash66%
→ $17Initiates → BuyGet Alert
06/29/2020ICPTBuy Now
Intercept Pharma
——
Edward Nash66%
→ $58DowngradeBuy → HoldGet Alert
06/19/2020RAREBuy Now
Ultragenyx Pharmaceutical
$38.69111.94%
Edward Nash66%
$80 → $82MaintainsBuyGet Alert
04/15/2020THTXBuy Now
Theratechnologies
$2.19402.28%
Edward Nash66%
$48 → $44MaintainsBuyGet Alert
02/10/2020AKROBuy Now
Akero Therapeutics
$45.24-20.42%
Edward Nash66%
→ $36Initiates → BuyGet Alert
01/30/2020MDGLBuy Now
Madrigal Pharmaceuticals
$343.29-42.32%
Edward Nash66%
→ $198Initiates → BuyGet Alert
01/10/2020RAREBuy Now
Ultragenyx Pharmaceutical
$38.69106.77%
Edward Nash66%
$75 → $80MaintainsBuyGet Alert
09/13/2019ADVMBuy Now
Adverum Biotechnologies
$4.9362.27%
Edward Nash66%
$120 → $80MaintainsHoldGet Alert
11/13/2018AKAOBuy Now
Achaogen
——
Edward Nash66%
$10 → $3DowngradeBuy → HoldGet Alert
11/02/2018ADVMBuy Now
Adverum Biotechnologies
$4.93—
Edward Nash66%
—DowngradeBuy → HoldGet Alert
10/29/2018RAREBuy Now
Ultragenyx Pharmaceutical
$38.6939.57%
Edward Nash66%
$83 → $54MaintainsBuyGet Alert
10/24/2018ETTXBuy Now
Entasis Therapeutics Hldg
——
Edward Nash66%
→ $20Initiates → BuyGet Alert
08/30/2018ADVMBuy Now
Adverum Biotechnologies
$4.93123.12%
Edward Nash66%
→ $110Initiates → BuyGet Alert
05/24/2018QUREBuy Now
uniQure
$14.36234.26%
Edward Nash66%
→ $48Initiates → BuyGet Alert
04/18/2018RAREBuy Now
Ultragenyx Pharmaceutical
$38.69—
Edward Nash66%
—UpgradeHold → BuyGet Alert
11/08/2017ABEOBuy Now
Abeona Therapeutics
$5.00420%
Edward Nash66%
→ $650Initiates → BuyGet Alert
09/22/2017VSARBuy Now
Versartis
——
Edward Nash66%
—DowngradeBuy → HoldGet Alert
08/23/2017RAREBuy Now
Ultragenyx Pharmaceutical
$38.6942.16%
Edward Nash66%
→ $55DowngradeBuy → HoldGet Alert
12/01/2016VSARBuy Now
Versartis
——
Edward Nash66%
→ $150Initiates → BuyGet Alert
04/14/2015VSARBuy Now
Versartis
——
Edward Nash66%
→ $300Initiates → BuyGet Alert
11/04/2014AKAOBuy Now
Achaogen
——
Edward Nash66%
→ $22Initiates → BuyGet Alert
10/16/2014RAREBuy Now
Ultragenyx Pharmaceutical
$38.69111.94%
Edward Nash66%
→ $82Initiates → BuyGet Alert